Maple Grove, MN – March 6, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Dicyclomine Hydrochloride Tablets, USP 20 mg. This product launch is a result of Upsher-Smith’s strategic partnership with CorePharma ... Read More
Maple Grove, MN – February 16, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are pleased to recognize 47 pharmacists from across the country with the 2022 NASPA ... Read More
Company Now Offers Contract Manufacturing and Packaging Capabilities
Maple Grove, MN – February 6, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith), a Midwest-based pharmaceutical company focused on specialty brands and generics, today announced the opening of ... Read More
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its fluoxetine product family with the launch of Fluoxetine Oral Solution, USP, 20 mg/5 mL. Upsher-Smith’s product is a generic version of the product, Prozac® ... Read More
Happy National Pharmacist Day! Upsher-Smith is proud to have been founded by a pharmacist—and later, to have found success because of another pharmacist. That’s why we’re similarly proud of our close partnership over the years ... Read More
Maple Grove, MN – November 7, 2022 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has extended its line of Haloperidol Tablets, USP and is now offering unit dose packaging in 1 mg, 5 ... Read More
